Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
17.29 (1y: +49%)
Market Cap 1.09 B P/E(ttm) 1330.00
Enterprise Value 1.95 B P/B 2.37
MDAS- NAS (USA)
MedAssets, Inc.
Not Rated
Top Ranked Predictable Companies
$17.29
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry		 vs
history
Cash to Debt 0.015
MDAS's Cash to Debt is ranked lower than
94% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 10000.00 vs. MDAS: 0.015 )
MDAS' s 10-Year Cash to Debt Range
Min: 0.02   Max: No Debt
Current: 0.02
Equity to Asset -0.551
MDAS's Equity to Asset is ranked lower than
97% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 0.49 vs. MDAS: -0.551 )
MDAS' s 10-Year Equity to Asset Range
Min: -1.24   Max: 0.41
Current: -0.55
-1.24
0.41
Interest Coverage 1.3
MDAS's Interest Coverage is ranked lower than
79% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 10000.00 vs. MDAS: 1.3 )
MDAS' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: 1.3
F-Score: 6
Z-Score: 0.57
M-Score: -3.16
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry		 vs
history
Operating margin (%) 13.30
MDAS's Operating margin (%) is ranked higher than
83% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 5.40 vs. MDAS: 13.30 )
MDAS' s 10-Year Operating margin (%) Range
Min: -5   Max: 17.6
Current: 13.3
-5
17.6
Net-margin (%) -1.1
MDAS's Net-margin (%) is ranked higher than
51% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 3.50 vs. MDAS: -1.1 )
MDAS' s 10-Year Net-margin (%) Range
Min: -8.2   Max: 16.7
Current: -1.1
-8.2
16.7
ROE (%) -1.6
MDAS's ROE (%) is ranked lower than
52% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 6.80 vs. MDAS: -1.6 )
MDAS' s 10-Year ROE (%) Range
Min: -7.4   Max: 4.6
Current: -1.6
-7.4
4.6
ROA (%) -0.4
MDAS's ROA (%) is ranked lower than
59% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 4.00 vs. MDAS: -0.4 )
MDAS' s 10-Year ROA (%) Range
Min: -3   Max: 7.5
Current: -0.4
-3
7.5
ROC (Joel Greenblatt) (%) 158.10
MDAS's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 21.20 vs. MDAS: 158.10 )
MDAS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 84.1   Max: 1562.4
Current: 158.1
84.1
1562.4
Revenue Growth (%) 17.2
MDAS's Revenue Growth (%) is ranked higher than
94% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 4.20 vs. MDAS: 17.2 )
MDAS' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 17.2
Current: 17.2
0
17.2
EBITDA Growth (%) 19.3
MDAS's EBITDA Growth (%) is ranked higher than
90% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 6.90 vs. MDAS: 19.3 )
MDAS' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 19.3
Current: 19.3
0
19.3
» MDAS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

MDAS Guru Trades in Q2 2012

Steven Cohen 1,547,834 sh (+20.36%)
Jim Simons 420,900 sh (-26.84%)
» More
Q3 2012

MDAS Guru Trades in Q3 2012

Steven Cohen 436,008 sh (-71.83%)
Jim Simons 112,000 sh (-73.39%)
» More
Q4 2012

MDAS Guru Trades in Q4 2012

Paul Tudor Jones 16,200 sh (New)
Jim Simons 212,000 sh (+89.29%)
Steven Cohen 629,037 sh (+44.27%)
» More
Q1 2013

MDAS Guru Trades in Q1 2013

Jim Simons 513,200 sh (+142.08%)
Steven Cohen 726,591 sh (+15.51%)
Paul Tudor Jones 17,700 sh (+9.26%)
» More
» Details

Insider Trades

Latest Guru Trades with MDAS

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2011-12-31 Sold Out 0.0022%$8.91 - $12.32 $ 17.2974%0
George Soros 2011-09-30 New Buy$9.4 - $13.99 $ 17.2953%13400
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 1330.00
MDAS's P/E(ttm) is ranked higher than
54% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 25.05 vs. MDAS: 1330.00 )
MDAS' s 10-Year P/E(ttm) Range
Min: 36.33   Max: 1500.77
Current: 1330
36.33
1500.77
P/B 2.37
MDAS's P/B is ranked lower than
61% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 1.90 vs. MDAS: 2.37 )
MDAS' s 10-Year P/B Range
Min: 1.24   Max: 3.85
Current: 2.37
1.24
3.85
P/S 1.54
MDAS's P/S is ranked lower than
56% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 1.40 vs. MDAS: 1.54 )
MDAS' s 10-Year P/S Range
Min: 0.92   Max: 4.22
Current: 1.54
0.92
4.22
PFCF 10.67
MDAS's PFCF is ranked higher than
68% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 18.41 vs. MDAS: 10.67 )
MDAS' s 10-Year PFCF Range
Min: 5.2   Max: 46.77
Current: 10.67
5.2
46.77
EV-to-EBIT 21.11
MDAS's EV-to-EBIT is ranked higher than
69% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 18.35 vs. MDAS: 21.11 )
MDAS' s 10-Year EV-to-EBIT Range
Min: 19.7   Max: 47
Current: 21.11
19.7
47
PEG 57.33
MDAS's PEG is ranked lower than
99% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 1.37 vs. MDAS: 57.33 )
MDAS' s 10-Year PEG Range
Min: 129.63   Max: 146.27
Current: 57.33
129.63
146.27
Shiller P/E 5053.8
MDAS's Shiller P/E is ranked higher than
95% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 22.91 vs. MDAS: 5053.8 )
MDAS' s 10-Year Shiller P/E Range
Min: 1489   Max: 5594.9
Current: 5053.8
1489
5594.9

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 20.4
MDAS's Price/Net Current Asset Value is ranked higher than
86% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 13.80 vs. MDAS: 20.4 )
MDAS' s 10-Year Price/Net Current Asset Value Range
Min: 9.6   Max: 27.2
Current: 20.4
9.6
27.2
Price/DCF (Projected) 1.2
MDAS's Price/DCF (Projected) is ranked lower than
68% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 1.40 vs. MDAS: 1.2 )
MDAS' s 10-Year Price/DCF (Projected) Range
Min: 0.7   Max: 1.8
Current: 1.2
0.7
1.8
Price/Median PS Value 0.9
MDAS's Price/Median PS Value is ranked higher than
76% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 0.80 vs. MDAS: 0.9 )
MDAS' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 1.9
Current: 0.9
0.5
1.9
Earnings Yield (Greenblatt) 4.70
MDAS's Earnings Yield (Greenblatt) is ranked higher than
81% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 4.80 vs. MDAS: 4.70 )
MDAS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.1   Max: 5.1
Current: 4.7
2.1
5.1
Forward Rate of Return (Yacktman) 16.13
MDAS's Forward Rate of Return (Yacktman) is ranked higher than
86% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 6.38 vs. MDAS: 16.13 )
MDAS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -12.3   Max: 17.3
Current: 16.13
-12.3
17.3

Business Description

Medassets, Inc. was incorporated in 1999. It provides technology-enabled products and services which together help mitigate the increasing financial pressures faced by hospitals and health systems. These include the increasing complexity of healthcare reimbursement, rising levels of bad debt and uncompensated care and significant increases in supply utilization and operating costs. Its solutions are designed to improve operating margin and cash flow for hospitals and health systems. The sustainable financial improvements provided by its solutions occur in a matter of months and can be quantified and confirmed by its customers. Its solutions integrate with its customers' existing operations and enterprise software systems and require minimal upfront costs or capital expenditures. The sustainable financial improvements provided by its solutions occur in a matter of months and can be quantified and confirmed by its customers. Its solutions integrate with its customers' existing operations and enterprise software systems and require minimal upfront costs or capital expenditures. The Company delivers its solutions through two business segments, Revenue Cycle Management (RCM) and Spend Management (SM). Its RCM segment provides a comprehensive suite of products and services spanning the hospital revenue cycle workflow — from patient access and financial responsibility, charge capture and integrity, pricing analysis, claims processing and denials management, payor contract management, revenue recovery and accounts receivable services. Its workflow solutions, together with its data management, decision support, performance analytics, and compliance and audit tools, increase revenue capture and cash collections, reduce accounts receivable balances and increase regulatory compliance. Its SM segment provides a comprehensive suite of technology-enabled services that help its customers manage their non-labor expense categories. Its solutions lower supply and medical device costs and utilization by managing the procurement process through its group purchasing organization's portfolio of contracts, consulting services and business analytics and intelligence tools. Its Spend Management segment helps its customers manage their non-labor expense categories through a combination of group purchasing, performance improvement consulting, including implantable physician preference items, or PPI, cost and utilization management and service line consulting, and business intelligence tools. The market for its products and services is fragmented, intensely competitive. As of December 31, 2011, its client base included more than 4,200 acute care hospitals and approximately 100,000 ancillary or non-acute provider locations. its group purchasing organization has contracts with more than 1,150 manufacturers, distributors and other vendors that pay us administrative fees based on purchase volume by its healthcare provider clients. The Company's revenue cycle m
Company Website
SEC Reports
Industry: Health Information Services
Compare:
» More Articles for MDAS

Headlines

Articles On GuruFocus.com
Steven Cohen Increases Two High-Growth Positions - OCZ Technology and MedAssets Inc. Apr 17 2012 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 9,000 Shares Mar 08 2011 
MEDASSETS, INC. Reports Operating Results (10-K) Mar 01 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Feb 09 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Jan 05 2011 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Dec 08 2010 
MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares Dec 01 2010 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Nov 09 2010 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Oct 07 2010 
MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares Sep 08 2010 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial